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lmmunocontraceptive Vaccines for Control of 
Fertility in the European Red Fox (Vulpes vulpes) 
Mark P. Bradley 
Abstract: This paper describes the strategies being requires the identification of gamete antigens that cause 
employed in the development of an immunocontraceptive immunological infertility, a detailed understanding of the 
vaccine using sperm antigens, to control fox populations in reproductive immunology of foxes, and the selection of the 
Australia. It is proposed that such a vaccine will be most effective form of antigen delivery system. 
delivered orally in a bait, thereby ultimately stimulating a 
mucosal immune response within the female reproductive Keywords: Sperm antigens, immunocontraception, 
tract. The eventual success in producing such a vaccine mucosal immunity 
Introduction 
lmmunocontraception potentially offers the most 
effective method for the management and long-term 
population control of vertebrate pest species. The 
idea of using fertility control for such purposes is not 
new. In the early 1960's, a number of investigators 
examined the use of chemical sterilants to limit the 
reproductive capacity of animal populations (Linhart 
1964). None of these methods proved effective, 
probably because these chemicals lead to castration 
of the target species. Castration removes the source 
of the key sex hormones, and this effect has the 
potential to interfere with the normal social structure of 
a target population, an undesirable outcome that could 
lead to a breakdown in established social hierarchies 
and may result in compensatory breeding. 
lmmunocontraception for Feral Species 
In 1992, the Cooperative Research Centre for the 
Biological Control of Vertebrate Pest Populations was 
established in Australia to explore alternative methods 
of fertility control based on the use of gamete antigens 
as immunogens. One of the species being targeted in 
this research is the European red fox (Vulpes), which 
is a major vertebrate pest in Australian responsible for 
the loss of many native species through predation. 
Our approach to immunocontraceptive control of 
the fox involves developing a bait-delivered oral 
vaccine. In this paper, I will discuss the experimental 
approaches used in the development of such a 
vaccine for foxes. Specifically, the focus will be on the 
identification of sperm antigens as vaccine candidates, 
the immunological questions that need to be addressed, 
and the development of appropriate delivery systems. 
Although these considerations are directed 
toward an application for the fox, many of the con- 
cepts are relevant for immunocontraception in other 
species. The wider concerns relating to species 
specificity, and the use of recombinant vaccines, will 
be covered in the paper by Tyndale-Biscoe in this 
proceedings. 
Components of an lmmunocontraceptive 
Vaccine for Feral Species 
A successful contraceptive vaccine should (1) block 
fertilization or early embryonic development; (2) affect 
both sexes; (3) be species specific; (4) provoke a 
prolonged and sustained immune response; and 
(5) not interfere with the normal social function of the 
animal. In particular, an effective mechanism for 
transmitting the vaccine throughout the target popula- 
tion must be found. This mechanism must be cost 
effective to manufacture and administer and must not 
impose hazards to the environment. These caveats 
make the development of an immunocontraceptive 
vaccine for wild animals highly challenging. 
Reproductive Studies 
Sperm Antigens as Targets for 
lmmunocontraception 
Vaccines developed toward sperm antigens would 
probably be capable of inducing infertility in both 
males and females. Potentially, this characteristic has 
the advantages not only of rendering sperm within the 
male genital tract incapable of fertilization before entry 
into the female but also of inactivating sperm within 
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the female genital tract. The direct immunization of 
males and females with extracts of sperm or testis 
results in a significant inhibition of fertility (Menge and 
Naz 1988). 
We have tested the antifertility effect of antibod- 
ies to sperm in a group of six female foxes (Bradley 
1994). Necropsy results revealed that there were 
21 ovulations in this group of foxes. In all females 
examined, no live fetuses were found; 13 of 21 
oocytes had been fertilized and embryos implanted, 
but all failed as determined by the presence of embry- 
onic resorption scars. Examination of uterine flushes 
failed to find any unfertilized or preimplantation 
embryos. It was concluded that immunization with 
sperm results in an immunological block to fertility and 
that sperm immunization has two effects, one at the 
embryonic level and the other during fertilization. 
The results of this experiment are consistent with 
those previously reported on the effect of experimen- 
tally induced sperm antibodies on fertility (O'Rand 
1977, Koyama et al. 1984). Many of these experi- 
ments found that anti-sperm antibodies appeared to 
exert their effect on fertility not at the level of fertiliza- 
tion but rather at later stages ranging from early 
blastocyst development to implantation (Menge and 
Naz 1988), suggesting that some antigens are shared 
between the sperm and the embryo. Immunization 
against such complex mixtures of antigens is not really 
a practical approach for vaccine development. Instead, 
the individual antigenic components capable of 
causing immunological contraception need to be 
identified. Indeed, a number of specific sperm pro- 
teins can impair fertility when used to immunize 
animals (Naz 1987, LeVan and Goldberg 1990). 
The most common approach to sperm antigen 
identification and selection is the use of monoclonal 
antibodies to sperm protein of the species under study 
(Anderson et al. 1987). One of the best examples is 
the PH-20 protein originally identified with monoclonal 
antibodies to guinea pig sperm. Fertility trials have 
shown that male and female guinea pigs immunized 
with PH-20 become infertile (Primakoff et al. 1988). 
More recently, the PH-20 genes from a number of 
other species have been cloned, leading to the 
possibility that this antigen may have applicability as a 
vaccine target in other species. 
Another sperm antigen of interest is SP-10. This 
has been designated as a "primary vaccine candidate" 
by the World Health Organization Task Force on 
Contraceptive Vaccines (Herr et al. 1990a and b). 
Antibodies to SP-10 inhibit the penetration of hamster 
eggs by human sperm, and trials in baboons currently 
in progress will assess the applicability of this antigen 
as an immunocontraceptive for humans. Recently, a 
homologue of SP-10 (called MSA-63) has been 
identified in the mouse and cloned (Liu et al. 1990). 
Furthermore, antibodies to MSA-63 have been shown 
to have a strong inhibitory effect on the in vitro fertili- 
zation of mouse ova, providing good support that this 
class of antigens is worthy of study as potential 
targets for immunocontraception. 
Fox Sperm Antigens Currently 
Being Assessed for Use in an 
lmmunocontraceptive Vaccine 
A number of monoclonal antibodies have been devel- 
oped to fox sperm antigens and used to clone the 
cognate genes from a fox testis cDNA library. One of 
these candidate antigens, FSA-lr, has been through 
fertility trial testing and found to have no effect on 
fertility. Other antigens are currently in the fertility trial 
phase of assessment. 
Fox Acr. 1 (Acrosomal Protein 1)  
The FSA-Acr.1 protein is located within the acrosomal 
matrix of fox sperm, and it is first detected during 
spermatogenesis on the developing acrosome of 
round and elongating spermatids (Beaton et al. 1995). 
A monoclonal antibody to FSA-Acr.1 (FSA-10) was 
used to screen a fox testis cDNA library, and a cDNA 
clone was isolated. Database searches with the 
deduced amino acid sequence of FSA-Acr.1 revealed 
that the clone has high homology to both human and 
baboon sperm protein SP-10 and the mouse sperm 
protein, MSA-63. The region of highest homology is 
within the carboxyl terminus. Within the central 
portion of the open reading frame, the fox sequence 
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contains amino acid motifs that are absent from both 
the human and baboon SP-10 and mouse MSA-63 
sequences. We have expressed the FSA-Acr.1 
protein in vitro, and this protein is being assessed in 
fertility trials to determine whether or not antibodies to 
FSA-Acr.1 can impair fertility. 
Fox LDH-C, 
Lactate dehydrogenase C, (LDH-C,) is an intracellular 
sperm-specific enzyme a portion of which is located 
on the sperm flagella plasma membrane. A number of 
studies have previously demonstrated that, when 
purified LDH-C, is used to immunize either mice, 
rabbits, or baboons, fertility was reduced by 60 to 80 
percent (LeVan and Goldberg 1990). Epitope map- 
ping studies of mouse and human LDH-C, have 
identified an antigenic peptide within the N-terminal 
region of the open reading frame, from amino acids 
5-19 (Millan et al. 1987). This sequence also has the 
greatest variation in sequence between different 
species. We have recently cloned a fox LDH-C, cDNA 
and have derived sequence information from the 5' 
region of the open reading frame. This research has 
enabled us to synthesize a peptide to this region that 
was subsequently conjugated to the tetanus toxoid 
protein as an immunogenic carrier protein. This 
peptide-protein conjugate has been used to immunize 
female foxes by the intra-Peyers' patch route, and the 
immune responses and the effects of this immuniza- 
tion on fox fertility are currently being measured. 
Cloning of the guinea pig PH-20 revealed that it has 
homology at the protein level with bee venom 
hylauronidase (Gmachl and Kreil 1993). Hylauronidase 
enzymatic activity is present within the head of mam- 
malian sperm, and it has been shown that PH-20 has 
hylauronidase enzymatic activity (Gmachl et al. 1993). 
We have isolated a cDNA from a fox testis cDNA 
library encoding PH-20, and partial sequence analysis 
indicates close homology to PH-20 antigens cloned 
from other species. The antifertility effects in foxes of 
PH-20 immunization will be assessed with the whole 
protein and with selected peptide sequences. 
Production of Recombinant Antigens 
The in vivo testing of candidate antigens requires the 
large-scale production of recombinant proteins. A 
number of commercially available protein expression 
systems exist for this purpose; however, the selection 
of the system for a particular purpose eventually 
depends on the properties of the antigen under study. 
For example, is the protein highly glycosylated, and 
how important is this for antigenicity? Or, is the 
protein composed of multiple subunits? These 
considerations all have bearing on the success and 
selection of any one expression system. We have 
extensively used the maltose binding protein (MBP) 
expression system for the production of recombinant 
sperm proteins. This system produces a fusion of 
MBP to the protein of interest. Following expression, 
the fusion product is purified by affinity chromatogra- 
phy to yield a hybrid protein. The MBP can be 
cleaved and purified from the target protein, but this 
has some drawbacks in that small amounts of MBP 
still contaminate the antigen preparations, and loss of 
antigen occurs at each purification step. Unfortu- 
nately, the selection of expression systems for produc- 
tion of recombinant proteins is still something of a 
trial-and-error procedure, and several systems may 
have to be evaluated before selection of one that suits 
the purpose of the antigen under study. 
In Vivo Fertility Testing of Recombinant 
Sperm Antigens 
Ideally, during the selection of monoclonal antibodies 
that identify candidate sperm vaccine antigens, part of 
the testing procedure should include the use of 
functional assay to determine the effect of these 
antibodies on either sperm-egg binding or fertilization 
in vitro. While such assays are readily available for 
some species, researchers are limited in the fox in the 
routine use of such assays by both the biology of 
foxes and the paucity of an in vitro fertilization assay 
system. Because the fox is a seasonal breeder, the 
availability of gametes for such studies is restricted to 
2 months every year, a fact that severely restricts the 
opportunity for assays. There is one reported study of 
attempts to establish an in vitro fertilization system for 
foxes. But, unfortunately, this procedure is still in the 
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early experimental stages, and its routine application 
is not feasible at present (Farstad et al. 1993). 
An alternative is to test the antifertility effects of 
candidate antigen(s) in vivo in female foxes. This 
approach is both time consuming and expensive, but it 
is highly informative. For example, we have routinely 
performed necropsies on the immunized foxes at 
about 40 days after mating to evaluate the biological 
implications of the immunization regime(s) on fox 
reproduction. At the same time, samples of reproduc- 
tive-tract fluids are collected for assays of the immu- 
noglobulin levels within each section of the tract. This 
approach provides information on both the immunol- 
ogy of the treatment and the in vivo effects on fertility. 
Do We Use Proteins or Peptides as 
Vaccine Antigens? 
Ultimately, the choice will have to be made as to 
whether a recombinant vaccine for immunocontra- 
ception is developed which contains the full target 
protein or an antigenic peptide. Decisions will have to 
be based on the considerations of the species speci- 
ficity of the antigen and the ability of any selected 
peptide epitope to produce a sufficient immune 
response to block fertility. The success of ongoing 
research on the selection, design, and construction of 
peptide antigens will be vital for the future develop- 
ment of peptide-based vaccines. 
lmmune Responses to Gamete 
Antigens 
Mucosal Immune Response in the 
Female Reproductive Tract 
The use of a bait-delivered oral immunocontraceptive 
for foxes requires a detailed understanding of the 
processes involved in the induction, modulation, and 
duration of genital tract mucosal immunity. The 
immune responses within the female genital tract are 
similar to that observed at other mucosal sites. 
Vaginal and cervical secretions contain high levels of 
immunoglobulin A (IgA) that appear to be locally 
synthesized. It has previously been shown that the 
reproductive mucosal site is linked to the common 
mucosal system and that IgA plasma cells stimulated 
at a distant site, such as the gastrointestinal tract, can 
rapidly migrate to the female reproductive tract 
(McDermott et al. 1980, Parr and Parr 1989 and 
1990). 
Using a model recombinant-derived antigen, 
maltose binding protein (MBP), we have investigated 
different immunization regimes to determine which 
route induces reproductive-tract mucosal immune 
responses within female foxes. Direct administration 
of antigen into the Peyers' patches (IPP) has been 
used because this route effectively mimics the oral 
presentation of an antigen to the gut associated 
lymphoid tissue (Dunkley and Husband 1990). 
Peyers' patch immunization induces a mucosal 
immune response within the female reproductive tract, 
but in the absence of a booster immunization, the 
antibody responses are transitory, particularly for IgA 
(fig. 1). This fact indicates that maintenance of vaginal 
IgA antibodies may require the antigen to persist. 
To examine this, an experiment was conducted 
to test the effect of secondary immunizations with 
MBP on the maintenance of vaginal antibody levels. 
Three female foxes were immunized IPP and then 
boosted intradermally (ID) 1 and 2 months later. The 
results show that the levels of both serum and vaginal 
antibodies were maintained at higher levels and for 
longer compared with foxes receiving a single Peyers' 
patch immunization (fig. 2). In light of this information, 
female foxes in fertility trials are now routinely immu- 
nized IPP followed by a secondary immunization ID, 
thus ensuring that high antibodies levels are present 
within the reproductive tract throughout the period of 
the fertility trial. 
lmmune Responses and the Endocrine 
System 
A number of studies have demonstrated that the sex 
hormones estrogen and progesterone can influence 
immunoglobulin G (IgG) and IgA antibody production 
within the female reproductive tract (McDermott et al. 
1980). Any immunocontraceptive vaccine strategy will 
have to address the effect that these localized 
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Figure 1. Serum and vaginal fluid antibody responses (Mean + SD; 
N = 3) in female foxes as determfned by enzyme-linked 
immunosorbent assay (ELISA). Each fox was immunized once 
with MBP into four Peyet's patches. 
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changes in the immune status of females may have on 
immunocontraception. Effective immunocontraception 
will depend on the maintenance of high levels of 
antisperm antibodies within the oviducts, uterus, and 
vagina during mating. If changes in the localized 
antibody concentrations are substantial during this 
critical period, then contraception may be compro- 
mised (Wira and Sandoe 1987). Studies are under 
way in the fox to determine if localized changes are 
seen in the reproductive tract IgG and IgA during 
estrus. 
Long-Term Maintenance of an Immune 
Response 
A problem that may need to be addressed in the 
administration of an immunocontraceptive vaccine to 
an outbred fox population is the variability of the 
immune response between individuals. Effective 
application of a vaccine for fertility control requires that 
a high level of immunity be achieved among individu- 
als exposed to the vaccine. It may, therefore, be 
necessary to include multiple antigenic determinants 
within a vaccine to stimulate a broad range of immune 
responses. In addition, the antigen(s) may need to be 
presented in conjunction with other highly immuno- 
genic carrier proteins to maintain a contraceptive level 
of immunity. 
Antigen Delivery Systems for a Fox 
lmmunocontraceptive Vaccine 
At present, three different vaccine delivery systems 
are being assessed to determine which will be the 
most effective for inclusion into the bait: (1) recombi- 
nant derived gamete antigen(s) encapsulated within 
microspheres, (2) a recombinant vaccinia virus 
capable of expressing foreign antigen(s) in the in- 
fected host, and (3) selected recombinant bacterial 
vectors such as the attenuated aroA strains of Salrno- 
nella typhirnuriurn. 
Figure 2. Serum and vaginal fluid antibody responses (Mean + SD; 
N =  3) in female foxes as determined by ELISA after immun~zation 
with MBP into four Peyer's patches, followed by intradermal 
booster mmunizatlons 1 and 2 months later. 
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Microencapsulated Antigens 
The effective oral presentation of antigens to the lower 
gastrointestinal tract is hampered by the degradation 
of protein within the stomach. A convenient way to 
overcome this is to use biodegradable microspheres 
that contain the entrapped antigen. These could be 
ultimately packaged within a bait, providing an effec- 
tive oral delivery system whereby the vaccine antigen 
is delivered directly to the gut. The microspheres are 
taken up by the mucosae with the subsequent induc- 
tion of a mucosal immune response (McGhee et al. 
1992). In recent years, a number of investigators 
have reported the successful application of this 
technique for the delivery of antigens and the subse- 
quent generation of mucosal immunity to the encapsu- 
lated antigens (Mestecky and Eldridge 1991). 
We have recently completed a study to evaluate 
the efficacy of microspheres containing a recombinant 
sperm antigen to stimulate a mucosal immune re- 
sponse in rats (Muir et al. 1994). Microspheres were 
synthesized using the poly-DL-lactide-co-glycolide 
copolymer incorporating a recombinant source of the 
fox sperm protein FSA-1 r (Bradley 1994). The oral 
administration of FSA-1 r-loaded microspheres to rats 
resulted in a significant production of cells within the 
jejunum that were secreting IgA antibodies specific for 
the FSA-l r antigen. The level of stimulation was 
comparable to that obtained by either direct immuniza- 
tion of the Peyers' patches with microspheres contain- 
ing antigen or unencapsulated antigen. These 
preliminary results indicate that further experiments 
would be worth pursuing to assess the utility of this 
approach for antigen delivery to foxes. 
Viral Vectors 
The use of recombinant vaccinia viral vectors contain- 
ing the genes encoding selected sperm antigens may 
offer an excellent delivery system for an immuno- 
contraceptive vaccine. For example, effective vacci- 
nation of foxes with a recombinant vaccinia expressing 
the rabies glycoprotein gene has proved enormously 
effective for immunizing foxes against rabies (Brochier 
et al. 1990). Building on these experiences, we are 
developing vaccinia vectors for application in 
immunocontraception. Such a system would allow 
further studies on the enhancement of the mucosal 
immunity, possibly by constructing vectors that 
coexpress IgA-specific stimulating cytokines (Ramsay 
et al. 1994). 
A preliminary assessment of the immunological 
responses in foxes to the oral administration of a 
recombinant vaccinia viral vector expressing the 
hemagglutinin antigen (HA) has begun, and the results 
of these experiments will provide a basis for further 
experiments designed to test the utility of using a 
recombinant poxviruses for the delivery of immuno- 
contraceptive antigens. 
Bacterial Vectors 
Recombinant bacterial vectors are an alternative 
delivery vehicle for a variety of vaccine antigens 
(Schodel 1992). The use of attenuated strains of 
Salmonella typhimurium as a live vector would be 
particularly applicable for stimulating reproductive tract 
mucosal immunity because Salmonella sp. colonize 
the intestinal tract and proliferate in the gut associated 
lymphoid tissue (Curtiss et al. 1989). 
The use of selected mutant strains of Salmonella 
sp, has the advantage that they can be made avirulent 
without decreasing immunogenicity and are not 
infective outside the host. These considerations are 
important for any recombinant vaccine being consid- 
ered for environmental release. However, a potential 
drawback is that immunity toward the carrier organism 
could develop, making subsequent exposure to the 
vaccine ineffective. 
We have conducted an experiment to assess 
whether the attenuated Salmonella typhimurium aroA 
mutant strain is capable of stimulating mucosal 
immune responses in foxes after oral administration. 
Such information is a prerequisite to any future use of 
this organism as a vaccine vector. We have found 
that foxes given oral doses of Salmonella typhimurium 
readily produce serum immunoglobulin M (IgM) and 
IgG, and vaginal IgG and IgA antibodies to Salmonella 
typhimurium lipopolysaccharide over a 6-week period. 
The results indicate that foxes can respond immuno- 
logically to a single oral dose of Salmonella 
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Figure 3. Serum IgG and IgM antibody responses (Mean + SD: 
N =  2) in female foxes to iipopolysaccharide antigen after one oral 
dose of 5 x 1 On Salmonella typhimurium (aroA mutant strain 
SL3261). 
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typhimurium that is sufficient to produce a high and 
sustained level of immunity within the female repro- 
ductive tract, albeit to a highly immunogenic antigen 
(figs. 3 and 4). Experiments are now in progress to 
construct a recombinant Salmonella typhimurium 
capable of expressing selected sperm antigens. Such 
recombinants will be screened for their ability to 
induce specific reproductive tract immune responses 
to the foreign antigen. 
Concluding Remarks 
Fertility control holds exciting prospects for the future 
management of wildlife populations. Internationally, a 
growing number of scientists and wildlife managers 
regard this approach as the only acceptable future 
method of managing wildlife populations. However, 
the obstacles that will be encountered in the develop- 
ment and implementation of such a technology are 
substantial. If the effort is successful, the rewards will 
be substantial, too. Each species will yield its own set 
of unique challenges. 
In this overview, I have summarized key aspects 
relating to the reproductive and immunological studies 
that are required in the process of developing an 
immunocontraceptive vaccine for a vertebrate pest 
species. I have attempted to address, albeit in a 
rather brief way, the major considerations that need to 
be taken in to account when contemplating the devel- 
opment of a fertility control vaccine for wildlife. I have 
not considered the wider ecological implications of 
fertility control being imposed on a wildlife population. 
Such studies pose a whole new set of questions and 
challenges, and any project concerned with fertility 
control of wildlife will require a large, integral ecology 
research program to match the other facets of the 
work. Eventually, it will be the ecological studies that 
will assess both the impact and long-term conse- 
quences of fertility control on a particular wildlife 
population. 
Figure 4. Vaglnal IgG and IgA antibody responses (Mean + SD: 
N =  3) in female foxes to iipopolysaccharide antigen after one oral 
dose of 5 x 1 O~almoneNa typhimurium (aroA mutant strain 
SL3261 I .  
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